Dexamethasone Trial

Comments Off on Dexamethasone Trial

This open label study was performed to assess the safety and tolerability of the EryDex System in people with A-T.


Betamethasone Trials

Comments Off on Betamethasone Trials

These trials studied whether a low dose betamethasone would reduce neurological symptoms associated with A-T.


Effect of Amantadine on Movement Disorder in A-T

Comments Off on Effect of Amantadine on Movement Disorder in A-T

This trial was performed to see if amantadine sulphate improves ataxia or other movement disorders associated with A-T.


Cerebrospinal Fluid Biomarker Study

Comments Off on Cerebrospinal Fluid Biomarker Study

Among the 204 identified CSF proteins, 13 showed significant changes in A-T patients versus control samples.


OxiDative Stress Clinical Trial

Comments Off on OxiDative Stress Clinical Trial

Two laboratory markers of oxidative stress improved when participants took both alpha-lipoic acid and nicotinamide.


L-Dopa Treatment Trial

Comments Off on L-Dopa Treatment Trial

No overall consistent improvement in neurologic function was observed on L-Dopa.


Nicotinamide Riboside (Niagen) Proof-of-concept Study

Comments Off on Nicotinamide Riboside (Niagen) Proof-of-concept Study

This trial in the Netherlands looked at the effects of nicotinamide ribose as a potential treatment for people with A-T.


PET Scan/FMRI Study

Comments Off on PET Scan/FMRI Study

Participants with A-T demonstrated lower brain activity or metabolism in the cerebellum as compared to control participants.


Baclofen Study

Comments Off on Baclofen Study

At the dose tested, Baclofen did not have a significant effect on tremor, eye movement or balance deficits.



Comments Off on ATTeST

This trial assessed the safety and efficacy of the EryDex System to treat neurological symptoms associated with A-T.